[HTML][HTML] Age-related modifications in CYP-dependent drug metabolism: role of stress
M Konstandi, EO Johnson - Frontiers in Endocrinology, 2023 - frontiersin.org
Accumulating clinical evidence indicates extensive inter-individual variations in the
effectiveness and adverse effects of standard treatment protocols, which are largely …
effectiveness and adverse effects of standard treatment protocols, which are largely …
Consequences of psychophysiological stress on cytochrome P450-catalyzed drug metabolism
M Konstandi, EO Johnson, MA Lang - Neuroscience & Biobehavioral …, 2014 - Elsevier
Most drugs are metabolized in the liver by cytochromes P450 (CYPs). Stress can modify
CYP-catalyzed drug metabolism and subsequently, the pharmacokinetic profile of a drug …
CYP-catalyzed drug metabolism and subsequently, the pharmacokinetic profile of a drug …
[HTML][HTML] Urinary metabolites of multiple volatile organic compounds among pregnant women across pregnancy: Variability, exposure characteristics, and associations …
M Li, Y Wan, X Qian, A Wang, G Mahai, Z He, Y Li… - Environment …, 2023 - Elsevier
Volatile organic compounds (VOCs) are a group of pollutants pervasive in daily life with
identified adverse health effects. However, no study has investigated the variability in VOC …
identified adverse health effects. However, no study has investigated the variability in VOC …
Cytochrome P450-2E1 promotes aging-related hepatic steatosis, apoptosis and fibrosis through increased nitroxidative stress
The role of ethanol-inducible cytochrome P450-2E1 (CYP2E1) in promoting aging-
dependent hepatic disease is unknown and thus was investigated in this study. Young (7 …
dependent hepatic disease is unknown and thus was investigated in this study. Young (7 …
Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation
Tamoxifen (TAM) is commonly used for cell type specific Cre recombinase-induced gene
inactivation and in cell fate tracing studies. Inducing a gene knockout by TAM and using non …
inactivation and in cell fate tracing studies. Inducing a gene knockout by TAM and using non …
[HTML][HTML] Potential pathogenetic link between angiomyofibroblastoma and superficial myofibroblastoma in the female lower genital tract based on a novel MTG1 …
R Tajiri, E Shiba, R Iwamura, C Kubo, A Nawata… - Modern Pathology, 2021 - Elsevier
Angiomyofibroblastoma and superficial myofibroblastoma are distinctive benign
mesenchymal tumors occurring in the female lower genital tract. Despite their significant …
mesenchymal tumors occurring in the female lower genital tract. Despite their significant …
Metabolism and toxicity of trichloroethylene and tetrachloroethylene in cytochrome P450 2E1 knockout and humanized transgenic mice
YS Luo, S Furuya, VY Soldatov, O Kosyk… - Toxicological …, 2018 - academic.oup.com
Trichloroethylene (TCE) and tetrachloroethylene (PCE) are structurally similar olefins that
can cause liver and kidney toxicity. Adverse effects of these chemicals are associated with …
can cause liver and kidney toxicity. Adverse effects of these chemicals are associated with …
Psychophysiological stress: a significant parameter in drug pharmacokinetics
M Konstandi - Expert Opinion on Drug Metabolism & Toxicology, 2013 - Taylor & Francis
Introduction: The available evidence suggests that psychophysiological stress regulates a
substantial number of factors, which in turn, can alter the pharmacokinetic parameters of a …
substantial number of factors, which in turn, can alter the pharmacokinetic parameters of a …
[HTML][HTML] High-resolution mass spectrometry identifies delayed biomarkers for improved precision in acetaminophen/paracetamol human biomonitoring
E Gorrochategui, M Le Vee, H Selmi, A Gérard… - Environment …, 2023 - Elsevier
Abstract Paracetamol/acetaminophen (N-acetyl-p-aminophenol, APAP) is a top selling
analgesic used in more than 600 prescription and non-prescription pharmaceuticals. To …
analgesic used in more than 600 prescription and non-prescription pharmaceuticals. To …
[HTML][HTML] Stress as a potential regulatory factor in the outcome of pharmacotherapy
M Konstandi, EO Johnson, MA Lang - Frontiers in Neuroscience, 2022 - frontiersin.org
Accumulating clinical evidence suggests significant inter-individual variations in the efficacy
of standard treatment protocols followed for several diseases, such as diabetes …
of standard treatment protocols followed for several diseases, such as diabetes …